1-2 of 2
Anders Almqvist, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Randomized Phase II Study Comparing Imatinib and the Combination of Imatinib and Pegylated Interferon Alpha-2b in Newly Diagnosed Non-High Risk Chronic Myeloid Leukemia (CML) Patients in Complete Hematological Remission After Imatinib Induction Therapy.

Bengt Simonsson, MD, Tobias Gedde-Dahl, MD, Berit Markevärn, MD, Kari Remes, MD, Jesper Stentoft, MD, Anders Almqvist, MD, Mats Björeman, MD, Max Flogegård, MD, Heikki Hallman, MD, Perttu Koskenvesa, MD, Anders Lindblom, MD, Claes Malm, MD, Satu Mustjoki, MD, Kristina Myhr-Eriksson, MD, Anu Räsänen, MD, Marjatta Sinisalo, MD, Risto Sippola, MD, Anders Själander, MD, Ulla Strömberg, MD, Ole Weiss Bjerrum, MD, Hans Ehrencrona, MD, Franz Gruber, MD, Veli Kairisto, MD, Karin RN Olsson, Arnon Nagler, MD, Johan Lanng Nielsen, MD, Henrik Hjorth-Hansen, MD, Kimmo Porkka, MD, for the Nordic CML Study Group (NCMLSG)
Journal: Blood
Blood (2009) 114 (22): 3280.
https://doi.org/10.1182/blood.V114.22.3280.3280
Published: 2009
Journal Articles

Clonal Large Granular Lymphocyte (LGL) Expansion Associated with Dasatinib Therapy.

Satu Mustjoki, MD, PhD, Tuisku Laurinolli, Marja Ekblom, MD, PhD, Auvo Rauhala, MD, PhD, Marjatta Sinisalo, MD, Anders Almqvist, MD, Elli Koivunen, MD, PhD, Tuija Lundan, Msc, Freja Ebeling, MD, PhD, Perttu Koskenvesa, MD, Henrik Hjorth-Hansen, MD, PhD, Petteri Arstila, MD, PhD, Leif Stenke, MD, PhD, Juan Luis Steegmann, MD, PhD, Martin Hoglund, MD, PhD, Bengt Simonsson, MD, PhD, Neil Shah, MD, PhD, Ronald Paquette, MD, PhD, Kimmo Porkka, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2938.
https://doi.org/10.1182/blood.V110.11.2938.2938
Published: 2007